Hosted on MSN16d
EU medicines agency quits X, moves to BlueskyAMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post ... as it decided on the use of vaccines in the European Union. The European Commission and other EU ...
The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...
A crackdown on the sale of counterfeit medicines online, coordinated by Europol, has resulted in the seizure of items worth ...
AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy ...
PALO ALTO, CA, USA I February 11, 2025 I BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused ...
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
AMSTERDAM, Jan 27 (Reuters) - The European Medicines Agency (EMA) said on Monday it ... as it decided on the use of vaccines in the European Union. The European Commission and other EU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results